On August 14, 2020, Johnson & Johnson Innovation – JJDC, Inc. announced an investment in Thirty Madison, a digital health company that markets direct-to-consumer telehealth services and medications for hair loss, migraines, and acid reflux. The $47 million Series B funding round was led by Polaris Partners. The size of the JJDC investment was not disclosed. Existing investors Maveron and Northzone also participated in the funding round. Thirty Madison has raised a total of $70 million to date.
Thirty Madison was founded in 2017. It has three portfolio brands—Keeps, Cove, and Evens. Each brand platform offers individualized health care to treat hair loss (Keeps), migraine (Cove), and acid reflux (Evens) at an affordable cost. Each brand provides virtual physician visits, a range of therapeutic treatments, tools, and individually tailored educational content.
With this new round of investment, Thirty Madison plans to further innovate in the digital health care space and launch new brands. Additionally, Amy Schulman, managing partner at Polaris Partners, will also join Thirty Madison’s Board of Directors. Ms. Schulman is a former president of Pfizer Consumer Healthcare.
This was reported by Thirty Madison on August 14, 2020.